{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:34:44Z","timestamp":1791876884871,"version":"4.3.4"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.carrev.2025.06.034","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:31:03Z","timestamp":1751427063000},"page":"120-125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The SAPIEN M3 system for transcatheter mitral valve replacement: A new era begins"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6121-2479","authenticated-orcid":false,"given":"Michail","family":"Penteris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7756-381X","authenticated-orcid":false,"given":"Konstantinos","family":"Lampropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2025.06.034_bb0005","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2025.06.034_bb0010","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1161\/CIRCULATIONAHA.119.043391","article-title":"Global, regional, and national burden of calcific aortic valve and degenerative mitral valve diseases, 1990\u20132017","volume":"141","author":"Yadgir","year":"2020","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.carrev.2025.06.034_bb0015","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/heartjnl-2024-324790","article-title":"Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography","volume":"111","author":"Playford","year":"2025","journal-title":"Heart"},{"key":"10.1016\/j.carrev.2025.06.034_bb0020","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/eurheartj\/ehm001","article-title":"Characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery","volume":"28","author":"Mirabel","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2025.06.034_bb0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12928-022-00898-4","article-title":"MitraClip: a review of its current status and future perspectives","volume":"38","author":"Kataoka","year":"2023","journal-title":"Cardiovasc Interv Ther"},{"issue":"6","key":"10.1016\/j.carrev.2025.06.034_bb0030","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.3390\/jcm13061799","article-title":"Ten future challenges in the field of transcatheter mitral valve edge-to-edge repair","volume":"13","author":"Orban","year":"2024","journal-title":"J Clin Med"},{"issue":"24","key":"10.1016\/j.carrev.2025.06.034_bb0035","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1016\/j.jacc.2021.04.051","article-title":"Current status and future prospects of transcatheter mitral valve replacement: JACC state-of-the-art review","volume":"77","author":"Alperi","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2025.06.034_bb0040","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jcin.2020.12.038","article-title":"Transcatheter mitral valve replacement: an update on current techniques, technologies, and future directions","volume":"14","author":"Hensey","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.06.034_bb0045","author":"Edwards Lifesciences"},{"issue":"11","key":"10.1016\/j.carrev.2025.06.034_bb0050","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2018.12.065","article-title":"Percutaneous transcatheter mitral valve replacement: first-in-human experience with a new transseptal system","volume":"73","author":"Webb","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"13_Supplement","key":"10.1016\/j.carrev.2025.06.034_bb0055","doi-asserted-by":"crossref","first-page":"B8","DOI":"10.1016\/j.jacc.2019.08.030","article-title":"TCT-8 updated 30-day outcomes for the U.S. early feasibility study of the SAPIEN M3 transcatheter mitral valve replacement system","volume":"74","author":"Makkar","year":"2019","journal-title":"JACC"},{"issue":"23","key":"10.1016\/j.carrev.2025.06.034_bb0060","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1016\/j.jcin.2023.09.032","article-title":"Transcatheter mitral valve replacement: 5 years later","volume":"16","author":"Husain","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"21","key":"10.1016\/j.carrev.2025.06.034_bb0065","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.3390\/jcm12216712","article-title":"Transcatheter mitral valve replacement using transcatheter aortic valve or dedicated devices: current evidence and future prospects","volume":"12","author":"Quentin","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.carrev.2025.06.034_bb0070","doi-asserted-by":"crossref","first-page":"531843","DOI":"10.3389\/fcvm.2020.531843","article-title":"Current devices in mitral valve replacement and their potential complications","volume":"7","author":"Gheorghe","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"9","key":"10.1016\/j.carrev.2025.06.034_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.121.010628","article-title":"Transcatheter mitral valve implantation: current status and future perspectives","volume":"14","author":"Russo","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.06.034_bb0080","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1161\/CIRCULATIONAHA.114.012525","article-title":"Outcomes after transapical or transfemoral transcatheter aortic valve replacement: PARTNER-I substudy","volume":"131","author":"Blackstone","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2025.06.034_bb0085","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jcin.2021.10.018","article-title":"Thirty-day outcomes after transfemoral transcatheter mitral valve replacement: results from the intrepid early feasibility study","volume":"15","author":"Zahr","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2025.06.034_bb0095","author":"Medical Device and Diagnostic Industry"},{"issue":"23","key":"10.1016\/j.carrev.2025.06.034_bb0100","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.jcin.2019.07.055","article-title":"Thrombotic risk and antithrombotic strategies after transcatheter mitral valve replacement","volume":"12","author":"Pagnesi","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.carrev.2025.06.034_bb0105","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jcin.2023.11.023","article-title":"First-in-human percutaneous excision of a failed MitraClip followed by transcatheter mitral valve replacement","volume":"17","author":"Elison","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"issue":"18","key":"10.1016\/j.carrev.2025.06.034_bb0110","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.jcin.2023.06.041","article-title":"5-year prospective evaluation of mitral valve-in-valve, valve-in-ring, and valve-in-MAC outcomes: MITRAL trial final results","volume":"16","author":"Guerrero","year":"2023","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925003471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925003471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T19:01:55Z","timestamp":1759431715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925003471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":21,"alternative-id":["S1553838925003471"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.06.034","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The SAPIEN M3 system for transcatheter mitral valve replacement: A new era begins","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.06.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}